6-AminoindazoleCAS# 6967-12-0 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 6967-12-0 | SDF | Download SDF |
| PubChem ID | 81423 | Appearance | Powder |
| Formula | C7H7N3 | M.Wt | 133 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 1H-indazol-6-amine | ||
| SMILES | C1=CC2=C(C=C1N)NN=C2 | ||
| Standard InChIKey | KEJFADGISRFLFO-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C7H7N3/c8-6-2-1-5-4-9-10-7(5)3-6/h1-4H,8H2,(H,9,10) | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
6-Aminoindazole Dilution Calculator
6-Aminoindazole Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 7.5188 mL | 37.594 mL | 75.188 mL | 150.3759 mL | 187.9699 mL |
| 5 mM | 1.5038 mL | 7.5188 mL | 15.0376 mL | 30.0752 mL | 37.594 mL |
| 10 mM | 0.7519 mL | 3.7594 mL | 7.5188 mL | 15.0376 mL | 18.797 mL |
| 50 mM | 0.1504 mL | 0.7519 mL | 1.5038 mL | 3.0075 mL | 3.7594 mL |
| 100 mM | 0.0752 mL | 0.3759 mL | 0.7519 mL | 1.5038 mL | 1.8797 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Tanshinone IIA-sulfonic sodium
Catalog No.:BCN2541
CAS No.:69659-80-9
- Didanosine
Catalog No.:BCC3763
CAS No.:69655-05-6
- Trichloro-1,4-dimethoxybenzene
Catalog No.:BCN3494
CAS No.:69653-71-0
- Hesperetin 5-O-glucoside
Catalog No.:BCN3934
CAS No.:69651-80-5
- 5'-Methoxynobiletin
Catalog No.:BCN8031
CAS No.:6965-36-2
- NSC 66811
Catalog No.:BCC2255
CAS No.:6964-62-1
- Pd-C-II
Catalog No.:BCN4599
CAS No.:
- H-D-Met-OMe.HCl
Catalog No.:BCC2998
CAS No.:69630-60-0
- H-D-Asp(OMe)-OMe.HCl
Catalog No.:BCC2897
CAS No.:69630-50-8
- Chamaejasmine
Catalog No.:BCN3132
CAS No.:69618-96-8
- CRT0044876
Catalog No.:BCC5109
CAS No.:6960-45-8
- 4-Hydroxybenzylamine
Catalog No.:BCN1805
CAS No.:696-60-6
- (Z-Cys-OH)2
Catalog No.:BCC2917
CAS No.:6968-11-2
- Mepiroxol
Catalog No.:BCC3810
CAS No.:6968-72-5
- Oleaside A
Catalog No.:BCN6772
CAS No.:69686-84-6
- 2,5-Dimethylchroman-4-one
Catalog No.:BCN7200
CAS No.:69687-87-2
- VIP (6-28) (human, rat, porcine, bovine)
Catalog No.:BCC5838
CAS No.:69698-54-0
- DCB
Catalog No.:BCC7212
CAS No.:6971-97-7
- 6-Amino-1-methyl-5-nitrosouracil
Catalog No.:BCC8756
CAS No.:6972-78-7
- Silvestrol
Catalog No.:BCC1948
CAS No.:697235-38-4
- CRSP-1
Catalog No.:BCC6043
CAS No.:697327-12-1
- BIS-TRIS
Catalog No.:BCC8028
CAS No.:6976-37-0
- W-9 hydrochloride
Catalog No.:BCC6623
CAS No.:69762-85-2
- 4-(3,4-Dimethoxyphenyl)-3-buten-1-ol
Catalog No.:BCN4258
CAS No.:69768-97-4
Ultrasound irradiation: a robust approach for direct functionalization of graphene oxide with thermal and antimicrobial aspects.[Pubmed:24613466]
Ultrason Sonochem. 2014 Jul;21(4):1407-16.
Sonochemical waves as mechanochemical energy was employed to exfoliate graphite oxide and functionalized graphene oxide (GrO), through a reaction of solvent and accountable for top-down and bottom-up approach respectively. The in situ formation of ester intermediate was inferred and a polymeric surface of GrO was further functionalized with 6-Aminoindazole (6-AIND) through sonochemical nucleophilic substitution reaction. As compared to conventional method the effect of ultrasound was verified for the direct functionalization of GrO. The conventional hazardous acylation step for functionalization of GrO was deleted in ultrasound assisted formation of f-(6-AIND) GrO nanocomposite, prepared by stereoselective exploitation of carboxyl groups at edges of GrO. The characterization has ascertained a covalent attachment of 6-AIND onto GrO surface with ATR-FTIR, XPS, SSNMR, TGA, DSC, XRD, AFM, RAMAN, EDX, SEM, BET and elemental analyzer. A weight loss in TGA depicts enhanced thermal stability of f-(6-AIND) GrO and a thermally sensitive behavior. The f-(6-AIND) GrO was studied for in vitro antimicrobial activity to ensure health and environmental safety. Antibacterial activity was identified against human pathogenic gram-positive (Staphylococcus aureus; ATCC 25923) and gram-negative bacteria (Escherichia coli; ATCC 25922). The antifungal activity was observed against Candida albicans (ATCC 10231).
